The CDK inhibitor p21 is a novel target gene of ATF4 and contributes to cell survival under ER stress

FEBS Lett. 2017 Nov;591(21):3682-3691. doi: 10.1002/1873-3468.12869. Epub 2017 Oct 11.

Abstract

Activating transcription factor 4 (ATF4) is well known for its role in the endoplasmic reticulum (ER) stress response. ATF4 also transcriptionally induces multiple effectors that determine cell fate depending on cellular context. In addition, ATF4 can communicate both pro-apoptotic and pro-survival signals. How ATF4 mediates its prosurvival roles, however, requires further investigation. Here, we report that the CDK inhibitor p21 is a novel target gene of ATF4. We identified two ATF4-responsive elements, one of which directly binds ATF4, within the first intron of the p21 gene. Importantly, overexpression of p21 enhances cell survival following ER stress induction, while p21 knockdown increases cell death. These results suggest that p21 induction plays a vital role in the cellular response to ER stress and indicate that p21 is a prosurvival effector of ATF4.

Keywords: ATF4; ER stress; p21.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 4 / genetics
  • Activating Transcription Factor 4 / metabolism*
  • Cell Survival
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • Cyclin-Dependent Kinase Inhibitor p21 / metabolism*
  • Endoplasmic Reticulum Stress / physiology*
  • Humans
  • Introns / physiology*
  • MCF-7 Cells
  • Response Elements / physiology*

Substances

  • ATF4 protein, human
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Activating Transcription Factor 4